AxoGen (NASDAQ: AXGN) reported Q2 EPS of ($0.03), $0.09 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $38.2 million versus the consensus estimate of $39.08 million.

For earnings history and earnings-related data on AxoGen (AXGN) click here.